Divestiture a Solution?I believe if RDW could find a buyer or JV for just the Device division. Spin off just the device part of the business. Perhaps another company that specialises only in Medical equipment and devices. This should generate enough cash flow to get us over to BTD and better valuation. There are two benefits, one is RDW can concentrate on the core business which is ACT and expand into Antivirus which is already in the works. It will reduce some payroll expenses and offer RDW and Dr. Mandel more time to work on the clinical study part and FDA relationship building to get us to the finish line. JMO